Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?

Stevenson AE, Evans BA, Gevers EF, Elford C, McLeod RW, Perry MJ, El-Kasti MM, Coschigano KT, Kopchick JJ, Evans SL, Wells T.

Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E147-56. doi: 10.1152/ajpendo.90689.2008. Epub 2008 Nov 11.

2.

Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency.

Davies JS, Gevers EF, Stevenson AE, Coschigano KT, El-Kasti MM, Bull MJ, Elford C, Evans BA, Kopchick JJ, Wells T.

Am J Physiol Endocrinol Metab. 2007 May;292(5):E1483-94. Epub 2007 Jan 30.

3.

The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats.

Evans BA, Bull MJ, Kench RC, Fox RE, Morgan LD, Stevenson AE, Gevers EF, Perry MJ, Wells T.

J Endocrinol. 2011 Jan;208(1):69-79. doi: 10.1677/JOE-10-0178. Epub 2010 Oct 20.

4.

Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats.

Evans BA, Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW, Wells T.

J Bone Miner Res. 2003 Jul;18(7):1308-16.

5.

Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice.

Oberbauer AM, Runstadler JA, Murray JD, Havel PJ.

Obes Res. 2001 Jan;9(1):51-8.

6.

Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.

Baldock PA, Allison S, McDonald MM, Sainsbury A, Enriquez RF, Little DG, Eisman JA, Gardiner EM, Herzog H.

J Bone Miner Res. 2006 Oct;21(10):1600-7.

8.

Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.

Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S.

J Endocrinol. 2006 Feb;188(2):263-70.

9.

Influences on quality of life in GH deficient adults and their effect on response to treatment.

Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.

Clin Endocrinol (Oxf). 1999 Nov;51(5):565-73.

PMID:
10594517
12.

PYY transgenic mice are protected against diet-induced and genetic obesity.

Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2008 Feb;42(1):19-30. doi: 10.1016/j.npep.2007.11.003. Epub 2007 Dec 27.

PMID:
18164057
13.

Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.

Wezeman FH, Emanuele MA, Emanuele NV, Moskal SF 2nd, Woods M, Suri M, Steiner J, LaPaglia N.

Alcohol Clin Exp Res. 1999 Sep;23(9):1534-42.

PMID:
10512321
14.

CART deficiency increases body weight but does not alter bone strength.

Bartell SM, Isales CM, Baile CA, Kuhar MJ, Hamrick MW.

J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):146-53.

15.

Role of the GH/IGF-I axis in the growth retardation of weaver mice.

Yao W, Bethin K, Yang X, Zhong J, Lee WH.

Endocrine. 2007 Oct;32(2):227-34. Epub 2007 Nov 27.

PMID:
18040896
16.
17.

Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory.

Collison KS, Makhoul NJ, Inglis A, Al-Johi M, Zaidi MZ, Maqbool Z, Saleh SM, Bakheet R, Mondreal R, Al-Rabiah R, Shoukri M, Milgram NW, Al-Mohanna FA.

Physiol Behav. 2010 Mar 3;99(3):334-42. doi: 10.1016/j.physbeh.2009.11.010. Epub 2009 Nov 27.

PMID:
19945473
18.

Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight.

Hamrick MW, Ding KH, Ponnala S, Ferrari SL, Isales CM.

J Bone Miner Res. 2008 Jun;23(6):870-8. doi: 10.1359/jbmr.080213.

19.

Is glutamate-induced reduction in growth hormone-releasing hormone a neuroendocrine model of aging in the rat?

Thompson MC, Norton NS, Rodriguez-Sierra JF, Lippiello L.

Proc Soc Exp Biol Med. 1994 May;206(1):69-75.

PMID:
8183964
20.

A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.

Sjögren K, Jansson JO, Isaksson OG, Ohlsson C.

Minerva Endocrinol. 2002 Dec;27(4):299-311. Review.

PMID:
12511852

Supplemental Content

Support Center